Transcriptional and immune signatures of ESR1 and PIK3CA co-mutations in HR+ MBC
Discovery of distinct immunosuppressive microenvironments to guide combination therapies
INDICATION
Breast
BIOMARKER
ESR1
Related cases
Discovery of distinct immunosuppressive microenvironments to guide combination therapies
Related cases